AG
CDMO

Advisor Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Advisor Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$33K Buy
4,260
+15
+0.4% +$88 ﹤0.01% 3687
2019
Q3 		$23K Sell
4,245
-3
-0.1% -$19 ﹤0.01% 3878
2019
Q2 		$24K Sell
4,248
-215
-5% -$886 ﹤0.01% 3878
2019
Q1 		$19K Buy
4,463
+215
+5% +$877 ﹤0.01% 4023
2018
Q4 		$18K Buy
4,248
+100
+2% +$522 ﹤0.01% 3892
2018
Q3 		$29K Buy
4,148
+972
+31% +$5.76K ﹤0.01% 3662
2018
Q2 		$12K Sell
3,176
-400
-11% -$1.39K ﹤0.01% 4002
2018
Q1 		$11K Sell
3,576
-143
-4% -$442 ﹤0.01% 4032
2017
Q4 		$14K Buy
3,719
+1,001
+37% +$4.29K ﹤0.01% 3910
2017
Q3 		$8K Buy
2,718
+289
+12% +$1.08K ﹤0.01% 4097
2017
Q2 		$10K Buy
2,429
+29
+1% +$119 ﹤0.01% 3939
2017
Q1 		$11K Buy
2,400
+114
+5% +$382 ﹤0.01% 3746
2016
Q4 		$5K Buy
2,286
+1,786
+357% +$4.17K ﹤0.01% 3956
2016
Q3 		$2K Buy
500
+357
+250% +$959 ﹤0.01% 4208
2016
Q2 		$0 Buy
+143
New +$399 ﹤0.01% 4524

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisor Group's CDMO Position: Q4 2019 in Review

Advisor Group increased its Avid Bioservices, Inc. Common Stock (CDMO) stake by 0.35% in Q4 2019, buying an estimated $88 and bringing the position to 4,260 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3687.

Advisor Group first reported a position in CDMO in Q2 2016 and has held it in 15 quarters since. 114 funds tracked by Wall St. Rank hold CDMO as of Q4 2019.

  • Advisor Group held 4,260 shares of Avid Bioservices, Inc. Common Stock worth $33K as of Q4 2019.
  • Advisor Group bought 15 Avid Bioservices, Inc. Common Stock shares in Q4 2019, an estimated $88.
  • Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3687 holding.
  • Advisor Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2016 and has held it in 15 quarters since.
  • 114 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.